<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Projects | UEA MED Genomics Pipelines</title>
    <link>/project/</link>
      <atom:link href="/project/index.xml" rel="self" type="application/rss+xml" />
    <description>Projects</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><lastBuildDate>Tue, 30 Jul 2019 00:00:00 +0000</lastBuildDate>
    <image>
      <url>/images/icon_hu0b7a4cb9992c9ac0e91bd28ffd38dd00_9727_512x512_fill_lanczos_center_2.png</url>
      <title>Projects</title>
      <link>/project/</link>
    </image>
    
    <item>
      <title>Cholesteatoma - rare variant discovery</title>
      <link>/project/cholesteatoma/</link>
      <pubDate>Tue, 30 Jul 2019 00:00:00 +0000</pubDate>
      <guid>/project/cholesteatoma/</guid>
      <description>&lt;h2 id=&#34;introduction&#34;&gt;Introduction&lt;/h2&gt;
&lt;p&gt;&lt;br /&gt;&lt;/p&gt;
&lt;p&gt;Cholesteatoma is a rare disorder that is characterised by a large mass of keratinising epithelium in the middle ear. The aetiology of the disease is largely unknown, therefore the UEA MED cholesteatoma genetics team utilised whole exome sequencing to identify germline mutants that may explain these clinical outcomes. We utilised our germline variant discovery pipeline (as described in the pipeline 
&lt;a href=&#34;https://uea-med-pipelines.netlify.app/publication/germline_variant/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;section&lt;/a&gt;) to analyse these samples. Below shows an example of some of the analyses included in the report generated for this project:&lt;/p&gt;
&lt;p&gt;&lt;br /&gt;&lt;/p&gt;
&lt;p&gt;&lt;br /&gt;&lt;/p&gt;
&lt;iframe
  src=&#34;chole_mock_v0.1.html&#34;
  style=&#34;width:100%; height:600px;&#34;
&gt;&lt;/iframe&gt;
&lt;p&gt;&lt;br /&gt;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Colorectal cancer tumoroid project</title>
      <link>/project/tumoroid_williams/</link>
      <pubDate>Tue, 30 Jul 2019 00:00:00 +0000</pubDate>
      <guid>/project/tumoroid_williams/</guid>
      <description>&lt;h2 id=&#34;introduction&#34;&gt;Introduction&lt;/h2&gt;
&lt;p&gt;&lt;br /&gt;&lt;/p&gt;
&lt;p&gt;Dr Mark Williams and his team are interested in the genetics of colorectal cancer, utilising complex 3D culturing techniques to identify potentially novel and effective treatment strategies. Dr Williams provided us with high quality DNA-exome sequences from patient matched tumoroid and organoid cultures to be processed by our somatic variant discovery pipeline. As described in our somatic pipelines 
&lt;a href=&#34;https://uea-med-pipelines.netlify.app/publication/somatic_variant/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;section&lt;/a&gt;, the sanger cgpWXS and GATK mutect2 tools were utilised to identify high confidence variants specific to tumour samples. Below shows an example of some summary results produced by this project:&lt;/p&gt;
&lt;p&gt;&lt;br /&gt;&lt;/p&gt;
&lt;p&gt;&lt;br /&gt;&lt;/p&gt;
&lt;iframe
  src=&#34;tumoroid_mock_v0.1.html&#34;
  style=&#34;width:100%; height:600px;&#34;
&gt;&lt;/iframe&gt;
&lt;p&gt;&lt;br /&gt;&lt;/p&gt;
</description>
    </item>
    
  </channel>
</rss>
